Michael Okonkwo

Michael Okonkwo

IPO & Growth Analyst

Michael Okonkwo is an IPO and growth equity analyst at StockTi. He holds an MBA from Wharton and previously worked in venture capital, giving him a unique perspective on pre-IPO valuations and public market debuts. Michael covers new listings, SPAC transactions, and high-growth companies across all sectors. His analysis focuses on identifying inflection points in emerging companies transitioning from private to public markets.

IPO, Growth Stocks 283 articles

Articles by Michael Okonkwo

SpaceX Shares Rebound 15.8% Post-Lockup, Still Below IPO Price
IPO

SpaceX Shares Rebound 15.8% Post-Lockup, Still Below IPO Price

SpaceX (SPCX) jumped 15.83% to $133.11 on Friday, but shares still sit 1.4% below the IPO price. Heavy capex in Space and AI segments raises valuation concerns despite Starlink's strong profits.

MS OPY BAC PIPR RKLB ASTS IRDM GSAT
Barrick Mining's North American IPO Faces Investor Pushback Amid Stock Surge
IPO

Barrick Mining's North American IPO Faces Investor Pushback Amid Stock Surge

Barrick Mining faces shareholder resistance over its planned North American IPO, which would list a minority stake in its key gold assets. The stock surged 19% last week.

B GLD NEM AEM KGC AU C RY JPM
SpaceX Stock Rebounds 23% as Share Float Swells 143%
IPO

SpaceX Stock Rebounds 23% as Share Float Swells 143%

SpaceX (NASDAQ:SPCX) closed Friday up 15.8% at $133.11, recovering from post-earnings losses as investors absorbed a 143% increase in share float. Q2 revenue surged 91.9% to $7.81B.

NVDA TSLA
SpaceX Stock Rebounds 23% Post-Lockup, Testing Cramer's Century Prediction
IPO

SpaceX Stock Rebounds 23% Post-Lockup, Testing Cramer's Century Prediction

SpaceX shares recovered 23% last week after a turbulent lockup period, closing near its IPO price. Q2 revenue surged 92%, but capital spending remains a concern.

TSLA NVDA NDAQ
Jersey Mike's IPO Falters as Trading Volume Dries Up Post-Debut
IPO

Jersey Mike's IPO Falters as Trading Volume Dries Up Post-Debut

Jersey Mike's shares slipped below their IPO price on Friday as trading volume dropped 95% from the debut. The stock closed at $22.91, down 0.4% from the $23 offering price.

BX CAVA WING CMG SG
Figma Faces Supply Test as 77.7M Shares Unlock After Earnings Drop
IPO

Figma Faces Supply Test as 77.7M Shares Unlock After Earnings Drop

Figma (FIG) faces a supply test as 77.7 million shares unlock Friday, adding pressure after a 14.9% earnings-driven decline.

FIG
SpaceX Faces $99B Lockup Expiry as AI Spending Surges
IPO

SpaceX Faces $99B Lockup Expiry as AI Spending Surges

SpaceX (NASDAQ:SPCX) faces a $99B lockup expiry on August 6, potentially doubling float. Q2 capex surged to $18.37B, 86% AI-focused, but shares fell 13.6%.

RKLB
Bending Spoons to Acquire Airtable in $2.25B Deal, Enterprise Value at 2.7x ARR
IPO

Bending Spoons to Acquire Airtable in $2.25B Deal, Enterprise Value at 2.7x ARR

Bending Spoons (NASDAQ:BSP) will acquire Airtable for $2.25 billion in cash, valuing the core business at $1.285 billion (2.7x ARR) after net cash.

L3Harris Shares Plunge $4.8B as Missile Unit IPO Delayed
IPO

L3Harris Shares Plunge $4.8B as Missile Unit IPO Delayed

L3Harris shares dropped 7.7% this week after a delayed missile IPO wiped out $4.8B in market value, despite strong Q2 earnings and record backlog.

LHX RTX NOC LMT GD
Jersey Mike's Recovers to $23 as Debt Concerns Loom
IPO

Jersey Mike's Recovers to $23 as Debt Concerns Loom

Jersey Mike's (NYSE:JMKE) shares recovered to $23 on Friday, erasing its debut decline, yet elevated debt and slowing same-store sales growth continue to pose challenges.

BX CAVA CMG WING
Apnimed Surges 56% in Nasdaq Debut as FDA Decision Looms
IPO

Apnimed Surges 56% in Nasdaq Debut as FDA Decision Looms

Apnimed (NASDAQ:APMD) closes its first day up 56% at $25, valuing the company near $1 billion as the FDA reviews its sleep apnea treatment.

INSP RMD LLY
Jersey Mike's IPO Stumbles: Shares Drop Below Offer Price
IPO

Jersey Mike's IPO Stumbles: Shares Drop Below Offer Price

Jersey Mike's (JMKE) fell 5.96% on its NYSE debut, erasing $435M in market value—more than its IPO proceeds. The stock closed at $21.63.

BX